Moderna’s Personalized mRNA Vaccine May Cut Melanoma Recurrence
A personalized Moderna mRNA vaccine used with immunotherapy may reduce melanoma recurrence, but the reported findings still require confirmation from the full clinical trial.
A personalized Moderna mRNA vaccine used with immunotherapy may reduce melanoma recurrence, but the reported findings still require confirmation from the full clinical trial.
AI is making cyberattacks faster, more personalized, and easier to scale. Here is what “Black October” means and how organizations can respond.
Nvidia shares rose despite Seaport reiterating its Sell rating and warning of mounting AI-chip competition. Investors now await evidence on market share, margins, and demand.
A verified round-trip Mars mission could transform planetary science by returning samples to Earth, while Phobos research could reveal how the Martian system formed.
Japan’s reported Phobos sample-return mission could clarify the moon’s origin, composition, relationship with Mars, and long-term evolution.
U.S. stocks ended a volatile week lower as AI selling, rising oil prices, inflation concerns and telecommunications risks pressured major indexes.
AI is making cyberattacks faster, cheaper, and more convincing. Learn how attackers use AI and which defenses businesses and individuals should prioritize.
Anthropic may seek to establish IPO terms before Thanksgiving slows dealmaking, but its reported growth must support a potentially unprecedented valuation.
An Argentine judge reportedly ended a fraud investigation into Javier Milei’s alleged role in a cryptocurrency controversy, while questions about the token remain unresolved.
Some iPhone Duo owners reportedly experienced hinge-area screen cracks soon after launch, raising durability concerns about Apple’s approximately $2,000 foldable phone.